Stay updated with breaking news from Caredx Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CareDx (NASDAQ:CDNA – Free Report) had its target price hoisted by Craig Hallum from $15.00 to $22.00 in a research note issued to investors on Friday morning, Benzinga reports. Craig Hallum currently has a buy rating on the stock. CDNA has been the topic of several other research reports. The Goldman Sachs Group raised their […]
CareDx (NASDAQ:CDNA – Free Report) had its price objective boosted by Stephens from $15.00 to $18.00 in a research report report published on Monday morning, Benzinga reports. Stephens currently has an overweight rating on the stock. Several other brokerages have also recently weighed in on CDNA. StockNews.com upgraded CareDx from a hold rating to a […]
CareDx (NASDAQ:CDNA – Get Free Report) and BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, valuation, profitability and analyst recommendations. Valuation and Earnings This table compares CareDx […]
Stephens reaffirmed their overweight rating on shares of CareDx (NASDAQ:CDNA – Free Report) in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has a $15.00 target price on the stock. CareDx Stock Up 3.0 % Shares of CDNA stock opened at $8.31 on Wednesday. The firm has a market cap of $430.29 […]
CareDx, Inc (NASDAQ:CDNA – Free Report) – Equities researchers at HC Wainwright lifted their FY2023 EPS estimates for shares of CareDx in a research note issued on Monday, January 29th. HC Wainwright analyst Y. Chen now forecasts that the company will earn ($1.76) per share for the year, up from their prior forecast of ($1.79). […]